InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Gray Peter, Director. Director active across 1 company, notably Jazz Pharmaceuticals plc. Aggregated, 7 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €354k. History available since 29 July 2021. The latest transaction was filed on 11 August 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
7 of 7 declarations
Peter Gray is a Board Member at Jazz Pharmaceuticals plc. He brings his expertise in governance and corporate strategy, actively participating in discussions and decisions within the board.